Clinical trial
Survival Benefit of ABO- or HLA- Incompatible Living Donor Kidney Transplantation in the Elderly.
NCT07436338 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Survival Benefit of ABO- or HLA- Incompatible Living Donor Kidney Transplantation in the Elderly.
- Lead sponsor
- Seoul National University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 1, 2010
- Completion date
- December 31, 2024
- Enrollment
- 1,819 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
end stage kidney disease (esrd), kidney transplant